All Stories

  1. Investigational drug therapies currently in early-stage clinical development for the treatment of clostridioides (clostridium) difficile infection

    Article • Expert Opinion on Investigational Drugs, February 2019, Taylor & Francis

    ellie Goldstein

  2. Comparative In Vitro Activity of Omadacycline against Dog and Cat Bite Wound Isolates

    Article • Antimicrobial Agents and Chemotherapy, February 2018, ASM Journals

    ellie Goldstein

  3. Comparative In Vitro Activities of Relebactam, Imipenem, the Combination of the Two, and Six Comparator Antimicrobial Agents against 432 Strains of Anaerobic Organisms, Including Imipenem-Resistant Strains

    Article • Antimicrobial Agents and Chemotherapy, November 2017, ASM Journals

    ellie Goldstein

  4. In Vitro Activities of Pexiganan and 10 Comparator Antimicrobials against 502 Anaerobic Isolates Recovered from Skin and Skin Structure Infections

    Article • Antimicrobial Agents and Chemotherapy, October 2017, ASM Journals

    ellie Goldstein

  5. In Vitro Activity of Pexiganan and 10 Comparator Antimicrobials against 234 Isolates, Including 93 Pasteurella Species and 50 Anaerobic Bacterial Isolates Recovered from Animal Bite Wounds

    Article • Antimicrobial Agents and Chemotherapy, April 2017, ASM Journals

    ellie Goldstein

  6. ComparativeIn VitroActivities of SMT19969, a New Antimicrobial Agent, against 162 Strains from 35 Less Frequently Recovered Intestinal Clostridium Species: Implications for Clostridium difficile Recurrence

    Article • Antimicrobial Agents and Chemotherapy, November 2013, ASM Journals

    ellie Goldstein

  7. ComparativeIn VitroActivities of SMT19969, a New Antimicrobial Agent, against Clostridium difficile and 350 Gram-Positive and Gram-Negative Aerobic and Anaerobic Intestinal Flora Isolates

    Article • Antimicrobial Agents and Chemotherapy, July 2013, ASM Journals

    ellie Goldstein

  8. In VitroActivity of Biapenem plus RPX7009, a Carbapenem Combined with a Serine β-Lactamase Inhibitor, against Anaerobic Bacteria

    Article • Antimicrobial Agents and Chemotherapy, March 2013, ASM Journals

    ellie Goldstein

  9. ComparativeIn VitroActivities of GSK2251052, a Novel Boron-Containing Leucyl-tRNA Synthetase Inhibitor, against 916 Anaerobic Organisms

    Article • Antimicrobial Agents and Chemotherapy, March 2013, ASM Journals

    ellie Goldstein